Johnson & Johnson said on Monday that the testing of an experimental vaccine against the coronavirus in humans will begin in September, and that a new vaccine may become available to permit emergency use at the beginning of 2021.
the Company also announced that in cooperation with the American Agency, Biomedical Advanced Research and Development Authority invested more than $ 1 billion in joint funding of research in the field of vaccines.
Johnson & Johnson plans to use against COVID-19 the same techniques that were used to develop candidate vaccines against Ebola virus, Zeke and HIV.
Administration trump has invested almost half a billion dollars in subsidies to Johnson & Johnson, Janssen Pharmaceuticals stimulating the search for a vaccine against coronavirus.
According to the world health organization (who), today the tests are only two vaccines: Moderna/NIAID and another in China from CanSino Biological and Beijing Institute of biotechnology.